Generated by Meeveem AI
"Pioneering biological artificial superintelligence for precision drug discovery and diagnostics"
Owkin is an AI biotechnology company using advanced agentic AI and biological reasoning models to untangle the complexity of human biology. The company processes complex patient data through its proprietary Patient Data Network, connecting research directly to care. Its AI agent, K Pro, drives insight generation and decision making across drug discovery and development. Owkin works with leading biopharmaceutical companies to identify new drug candidates, de-risk and accelerate clinical trials, and build diagnostic solutions that improve patient outcomes. Its AI diagnostic tests, including MSIntuit for colorectal cancer and RlapsRisk for breast cancer, support pathologists with accurate diagnosis.
357
Team Members
2016
Founded
Digital Health
Sector
Hybrid
Work Environment
A world where research and development is fully automated, with millions of AI scientists working in parallel to hypothesize, plan, and run experiments, ushering in a new era of biological understanding and connecting research directly to care.
At Owkin, our mission is to unlock complex biology through biological artificial superintelligence, finding the right treatment for every patient by connecting research to care.